9 Jun 2021 15:28
GlaxoSmithKline plc (the 'Company')
Â
Transaction notification
Â
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Dr H Barron | |||
b) | Position/status | Chief Scientific Officer and President, R&D | |||
c) | Initial notification/ amendment | Initial notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | American Depositary Shares ('ADSs') Â ISIN: US37733W1053 | |||
b) | Nature of the transaction | Acquisition of notional ADSs within Dr Barron's GSK Executive Supplemental Savings Plan account following the reinvestment of dividends  | |||
c) | Price(s) and volume(s) | Â | Price(s) | Volume(s) | Â |
 | $38.75 | 1,194.932 |  | ||
 |  |  |  | ||
d) | Aggregated information   | N/A (single transaction) | |||
Aggregated volume Price | Â | ||||
e) | Date of the transaction | 2021-06-07 | |||
f) | Place of the transaction  | New York Stock Exchange (XNYS) |
Â
Â